Conference Details - Agenda

View all Conferences

Continuing Education Information

Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource designates this educational activity for a maximum of 24.5 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.

Registered Nurses: The California Board of Registered Nursing accepts AMA PRA Category 1 Credits ™ toward license renewal. On the BRN license renewal form, report the number of hours you attended (up to 24.5 hours of credit) and fill in “CME Category 1” for the provider number.

California AB 1195: This activity complies with California Assembly Bill 1195, signed November 2005, requiring continuing medical education courses with patient care components to include curricula in the subject of cultural and linguistic competency. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area.

11th International Lung Cancer Congress

Terranea
Rancho Palos Verdes, CA
July 8-11, 2010

Thursday, July 8, 2010

6:30 am Breakfast and Registration
7:00 am Welcome and Introductions
7:05 am Presession Survey
State of the Art: Early-Stage NSCLC
Chair: David Gandara
7:15 am Stage vs. Molecular Markers in Selecting Adjuvant Therapy for Stage IIA NSCLC
Stage: Stephen Swisher
Molecular Markers: Heather Wakelee
7:45 am Question-and-Answer Session
7:50 am How I Manage: Optimal Management of Patients With Early NSCLC and Compromised Lung Function
Walter Curran, Jr
8:10 am Question-and-Answer Session
8:15 am When Are Sublobar Resections Appropriate?
Harvey I. Pass
8:35 am Question-and-Answer Session
8:40 am Restaging After Induction Therapy for Stage III NSCLC
David M. Jablons
9:00 am Question-and-Answer Session
9:05 am Keynote Lecture: Neoadjuvant and Adjuvant Chemotherapy
Frances Shepherd
9:35 am Question-and-Answer Session
9:40 am Panel Discussion: Implications of the IASLC Staging Project
Moderators: Harvey I. Pass, Masahiro Tsuboi
10:10 am Break
Maintenance and Second-line Therapy in Advanced NSCLC
Chair: Roy Herbst
10:25 am Definition and Goals of Maintenance Therapy
Karen Kelly
10:45 am Question-and-Answer Session
10:50 am Cytotoxic Agents
Glenwood Goss
11:10 am Question-and-Answer Session
11:15 am Targeted Agents
Thomas Lynch
11:35 am Question-and-Answer Session
11:40 am Approaches to the Second-line Treatment of Metastatic NSCLC
Joan H. Schiller
12:00 pm Postsession Survey
12:05 pm Case-Based Panel Discussion: Maintenance Therapy
Moderator: Karen Kelly
12:25 pm Poster Discussion 1
Kemp H. Kernstine
12:45 pm Adjourn
Workshop 1
2:00 pm-4:00 pm The Next Generation of Targeted Agents in Lung Cancer (CME-Designated Workshop)
Chair: Michael S. O'Reilly
2:00 pm ALK Inhibitors
Tianhong Li
2:15 pm Question-and-Answer Session
2:20 pm Targeting PI3K/Akt
Alex A. Adjei
2:35 pm Question-and-Answer Session
2:40 pm PARP Inhibitors
David Gandara
2:55 pm Question-and-Answer Session
3:00 pm MEK Inhibitors
Michael S. O'Reilly
3:15 pm Question-and-Answer Session
3:20 pm VEGFR TKIs: Where Do We Go From Here?
Alex A. Adjei
3:35 pm Question-and-Answer Session
3:40 pm c-Met Inhibitors
Primo N. Lara, Jr
3:55 pm Question-and-Answer Session
4:00 pm Overcoming T790M Mutations
Karen Kelly
4:15 pm Question-and-Answer Session
4:20 pm Adjourn
6:30 pm-7:30 pm Welcome Reception
(Palos Verdes Terrace)
Download Conference Agenda

Educational Grants

An educational grant for this activity was provided by:


  1. Lilly USA, LLC
  3. Bristol-Myers Squibb
  4. Genentech BioOncology/OSI Oncology
  6. Boehringer Ingelheim Pharmaceuticals, Inc.
  8. Abraxis BioScience
  9. Bonnie J. Addario Lung Cancer Foundation
  10. Novartis Oncology